Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06749366
Recruiting
Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Not applicable · United States · 1 site
Registry update: 1 Oct 2026
NCT06943612
Recruiting
Colorectal Resections in Patients With Retroperitoneal Sarcoma
Not applicable · Switzerland, Germany · 16 sites
Registry update: 23 Jul 2026
NCT06789172
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Phase 1 · Australia, United Kingdom, United States · 10 sites
Registry update: 11 Jun 2026
NCT07032285
Recruiting
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Phase 2 · Spain · 8 sites
Registry update: 6 Apr 2026
Conflicting statuses (not updated in the registry for 7 months)
NCT06674811
Recruiting
Biomarkers of Resiliency In Childhood Cancer Surgery
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT06650514
Recruiting
A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma
Phase 2 · Spain · 1 site
Registry update: 10 Jan 2025
Conflicting statuses (not updated in the registry for 21 months)
2024-520318-23-00
Recruiting
Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
Phase 1/2 · Spain · 10 sites
Registry update: 28 Oct 2026
NCT06456359
Recruiting
Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
Phase 2 · Germany · 3 sites
Registry update: 13 Jan 2025
NCT06836505
Recruiting
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
Phase 1/2 · China · 3 sites
Registry update: 26 Feb 2025
NCT06645808
Recruiting
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Early phase 1 · Netherlands · 1 site
Registry update: 29 Dec 2025
Conflicting statuses (not updated in the registry for 10 months)
NCT06580002
Recruiting
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · United States · 1 site
Registry update: 14 Jul 2026
NCT07915895
Recruiting
Retroperitoneal Tumor Registry
Not applicable · China · 1 site
Registry update: 4 Nov 2026
NCT06684327
Recruiting
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Phase 2 · China · 1 site
Registry update: 20 Dec 2024
2024-518199-30-00
Recruiting
Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients
Phase 1/2 · Spain, France, Italy · 15 sites
Registry update: 4 Sept 2026
NCT07602049
Recruiting
Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 22 May 2026
NCT06683846
Recruiting
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · China · 1 site
Registry update: 24 Aug 2025
NCT06988475
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Phase 2/3 · United Kingdom · 17 sites
Registry update: 24 Nov 2025
NCT06644755
Recruiting
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Phase 1 · Belgium, France, South Korea, Netherlands, United States · 7 sites
Registry update: 4 Sept 2026
NCT06714383
Recruiting
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Phase 2 · China · 1 site
Registry update: 3 Dec 2024
NCT06641908
Recruiting
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Phase 1 · Belgium, Switzerland, France, United Kingdom, Japan, United States · 11 sites
Registry update: 5 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.